ALVO vs VTRS

For growth investors, Alvotech (ALVO) is the stronger pick with 19.

7% revenue growth year-over-year, versus -3. 0% for Viatris Inc. (VTRS). Alvotech (ALVO) offers the better valuation at 32. 0x trailing P/E (100. 9x forward), making it the more compelling value choice. Analysts rate Alvotech (ALVO) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Viatris Inc.

is actually cheaper at 7. 1x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Viatris Inc.

(VTRS) delivered a total return of +40. 3%, compared to -71. 4% for Alvotech (ALVO). Over 10 years, the gap is even starker: VTRS returned -51. 5% versus ALVO's -71. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Viatris Inc.

(VTRS) is the lower-risk stock at 0. 99β versus Alvotech's 1. 11β — meaning ALVO is approximately 11% more volatile than VTRS relative to the S&P 500.

By revenue growth (latest reported year), Alvotech (ALVO) is pulling ahead at 19.

7% versus -3. 0% for Viatris Inc. (VTRS). On earnings-per-share growth, the picture is similar: Alvotech grew EPS 111. 5% year-over-year, compared to -466. 0% for Viatris Inc.. Over a 3-year CAGR, ALVO leads at 91. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Alvotech (ALVO) is the more profitable company, earning 4.

8% net margin versus -24. 6% for Viatris Inc. — meaning it keeps 4. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALVO leads at 13. 3% versus -18. 6% for VTRS. At the gross margin level — before operating expenses — ALVO leads at 59. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Viatris Inc.

(VTRS) trades at 7. 1x forward P/E versus 100. 9x for Alvotech — 93. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ALVO: 168. 7% to $8. 60.

In this comparison, VTRS (2.

8% yield) pays a dividend. ALVO does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Viatris Inc.

(VTRS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 99), 2. 8% yield). Both have compounded well over 10 years (VTRS: -51. 5%, ALVO: -71. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: ALVO is a small-cap high-growth stock; VTRS is a mid-cap quality compounder stock. VTRS pays a dividend while ALVO does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.